ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Free cash flow 2016–2025
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$156.9MFY2025 · since FY2016: -$68.3M → $156.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $156.9M | +126.0% |
| FY2024 | -$604.3M | -82.8% |
| FY2023 | -$330.6M | -75.0% |
| FY2022 | -$188.9M | -227.9% |
| FY2021 | $147.7M | +237.1% |
| FY2020 | -$107.8M | -166.9% |
| FY2019 | $161.0M | +431.0% |
| FY2018 | -$48.6M | -52.7% |
| FY2017 | -$31.9M | +53.3% |
| FY2016 | -$68.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice